共 109 条
[1]
Lip G.Y.H.(2002)Antithrombotic therapy for atrial fibrillation BMJ 325 1022-1025
[2]
Hart R.G.(2001)Antithrombotic therapy in atrial fibrillation Chest 119 194S-206S
[3]
Conway D.S.G.(2001)ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation J Am Coll Cardiol 38 1231-1266
[4]
Albers G.W.(1987)Atrial fibrillation: a major contributor to stroke in the elderly The Framingham Study. Arch Intern Med 147 1561-1564
[5]
Dalen J.E.(1987)Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1449-1457
[6]
Laupacis A.(1999)Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis Ann Intern Med 131 492-501
[7]
Fuster V.(2003)Lessons from the stroke prevention in atrial fibrillation trials Ann Intern Med 138 831-839
[8]
Ryden L.E.(1989)Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFaSAK study Lancet 1 175-179
[9]
Wolf P.A.(1989)Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II study Lancet 343 687-691
[10]
Abbott R.D.(2000)Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies Cerebrovasc Dis 10 39-43